Treatment with adalimumab (Humira®) is safe and effective in psoriatic arthritis (PsA) patients in real-life clinical practice:: Preliminary results of the stereo trial

被引：0
|
作者：
Vandenbosch, F. [1 ]
McHugh, N. J. [2 ]
Reece, R. [3 ]
Cooper, R. [4 ]
Manger, B. [5 ]
Goupille, P. [6 ]
FitzGerald, O. [7 ]
Kron, M. [8 ]
Frank, M. [8 ]
Kupper, H. [8 ]
Roedevand, E. [9 ]
Holck, P. [10 ]
VanVollenhoven, R. [11 ]
Leirisalo-Repo, M. [12 ]
机构：
[1] Univ Hosp, Ghent, Belgium
[2] Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England
[3] Huddersfield Royal Infirm, Huddersfield, W Yorkshire, England
[4] Hope Hosp, Salford M6 8HD, Lancs, England
[5] Univ Erlangen Nurnberg, Erlangen, Germany
[6] CHU Tours, Hop Trousseau, Tours, France
[7] St Vincents Univ Hosp, Dublin, Ireland
[8] Abbott GmbH & Co KG, Ludwigshafen, Germany
[9] St Olavs Hosp, Trondheim, Norway
[10] Silkeborg Centralsygehus, Silkeborg, Denmark
[11] Karolinska Univ Hosp, Stockholm, Sweden
[12] Univ Hosp, Helsinki, Finland
来源：
RHEUMATOLOGY | 2007年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：I52 / I53
页数：2
相关论文
共 50 条
  • [41] Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data (vol 7, pg 485, 2017)
    Dattola, Annunziata
    Cannizzaro, Maria Vittoria
    Mazzeo, Mauro
    Bianchi, Luca
    DERMATOLOGY AND THERAPY, 2018, 8 (01) : 171 - 171
  • [42] Real-world evidence of biologic treatments in psoriatic arthritis in Italy: results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in Italy: an ObservatioNal lOngitudinal Study of real-life clinical practice) observational longitudinal study
    Colombo, Delia
    Frassi, Micol
    Mariano, Giusy Pagano
    Fusaro, Enrico
    Lomater, Claudia
    Del Medico, Patrizia
    Iannone, Florenzo
    Foti, Rosario
    Limonta, Massimiliano
    Marchesoni, Antonio
    Raffeiner, Bernd
    Viapiana, Ombretta
    Grassi, Walter
    Grembiale, Rosa Daniela
    Guggino, Giuliana
    Mazzone, Antonino
    Tirri, Enrico
    Perricone, Roberto
    Puttini, Pier Carlo Sarzi
    De Vita, Salvatore
    Conti, Fabrizio
    Ori, Alessandra
    Simoni, Lucia
    Fiocchi, Martina
    Orsenigo, Roberto
    Zagni, Emanuela
    BMC RHEUMATOLOGY, 2022, 6 (01)
  • [43] Real-Life Treatment Persistence with Golimumab (GLM), Etanercept (ETA), and Adalimumab (ADA) in Patients with Rheumatoid Arthritis in Canada
    Monfared, Amir Abbas Tahami
    Khalil, Hayssam
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 327 - 327
  • [44] Real-world evidence of biologic treatments in psoriatic arthritis in Italy: results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in Italy: an ObservatioNal lOngitudinal Study of real-life clinical practice) observational longitudinal study
    Delia Colombo
    Micol Frassi
    Giusy Pagano Mariano
    Enrico Fusaro
    Claudia Lomater
    Patrizia Del Medico
    Florenzo Iannone
    Rosario Foti
    Massimiliano Limonta
    Antonio Marchesoni
    Bernd Raffeiner
    Ombretta Viapiana
    Walter Grassi
    Rosa Daniela Grembiale
    Giuliana Guggino
    Antonino Mazzone
    Enrico Tirri
    Roberto Perricone
    Pier Carlo Sarzi Puttini
    Salvatore De Vita
    Fabrizio Conti
    Alessandra Ori
    Lucia Simoni
    Martina Fiocchi
    Roberto Orsenigo
    Emanuela Zagni
    BMC Rheumatology, 6
  • [45] TOCILIZUMAB IN SYSTEMIC AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS: RESULTS OF A RETROSPECTIVE EVALUATION IN REAL-LIFE CLINICAL PRACTICE
    Bustabad, S.
    Bethencourt, J. J.
    Prieto Morales, M.
    Peiro Callizo, M. E.
    Gamir Gamir, M. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 1001 - 1001
  • [46] Utilization Pattern of Golimumab (Simponi®) in Patients with Inflammatory Arthritis in Real-Life Clinical Practice in Canada
    Abbas, Amir
    Monfared, Tahami
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 41 - 41
  • [47] Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant Population
    Berman, Julia
    Furer, Victoria
    Berman, Mark
    Isakov, Ofer
    Zisman, Devy
    Haddad, Amir
    Elkayam, Ori
    BIOLOGICS-TARGETS & THERAPY, 2021, 15 : 463 - 470
  • [48] Bortezomib retreatment is effective in relapsed multiple myeloma patients - real-life clinical practice data
    Stork, M.
    Sevcikova, S.
    Brozova, L.
    Spicka, I
    Maisnar, V
    Minarik, J.
    Jungova, A.
    Gregora, E.
    Velichova, R.
    Hajek, R.
    Jelinek, T.
    Pour, L.
    NEOPLASMA, 2020, 67 (01) : 178 - 184
  • [49] TREATMENT WITH IXEKIZUMAB FOLLOWING SECUKINUMAB FAILURE IN PATIENTS WITH PSORIATIC ARTHRITIS: REAL-LIFE EXPERIENCE FROM A RESISTANT POPULATION
    Berman, J.
    Furer, V.
    Berman, M.
    Isakov, O.
    Zisman, D.
    Haddad, A.
    Matz, H.
    Elkayam, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1309 - 1310
  • [50] RESULTS OF INTERIM ANALYSIS OF A RETROSPECTIVE IGIBD STUDY ON ADALIMUMAB USE IN REAL PRACTICE IN ITALY: THE REAL-LIFE CLINICAL EFFECTIVENESS OF ADALIMUMAB IN ULCERATIVE COLITIS (REALADA-UC) STUDY
    Pugliese, Daniela
    Mendolaro, Marco
    D'Inca, Renata
    Ribaldone, Davide G.
    Principi, Mariabeatrice
    Ricci, Chiara
    Stasi, Elisa
    Scribano, Maria Lia
    Bodini, Giorgia
    Saibeni, Simone
    Privitera, Antonino C.
    Simondi, Daniele
    Armuzzi, Alessandro
    Daperno, Marco
    GASTROENTEROLOGY, 2019, 156 (06) : S887 - S887
12345